These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 37096808)

  • 1. Regulation of CD8 T-cell signaling, metabolism, and cytotoxic activity by extracellular lysophosphatidic acid.
    Torres RM; Turner JA; D'Antonio M; Pelanda R; Kremer KN
    Immunol Rev; 2023 Aug; 317(1):203-222. PubMed ID: 37096808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LPA
    Mathew D; Kremer KN; Strauch P; Tigyi G; Pelanda R; Torres RM
    Front Immunol; 2019; 10():1159. PubMed ID: 31231367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophosphatidic acid inhibits CD8 T cell activation and control of tumor progression.
    Oda SK; Strauch P; Fujiwara Y; Al-Shami A; Oravecz T; Tigyi G; Pelanda R; Torres RM
    Cancer Immunol Res; 2013 Oct; 1(4):245-55. PubMed ID: 24455753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LPA suppresses T cell function by altering the cytoskeleton and disrupting immune synapse formation.
    Kremer KN; Buser A; Thumkeo D; Narumiya S; Jacobelli J; Pelanda R; Torres RM
    Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2118816119. PubMed ID: 35394866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of chemoresistance by lysophosphatidic acid (LPA) signaling through LPA
    Minami K; Ueda N; Maeda H; Ishimoto K; Otagaki S; Tsujiuchi T
    Biochem Biophys Res Commun; 2019 Sep; 517(2):359-363. PubMed ID: 31362892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of lysophosphatidic acid receptor 5 is necessary for the regulation of intestinal Na
    Jenkin KA; He P; Yun CC
    Am J Physiol Gastrointest Liver Physiol; 2018 Oct; 315(4):G433-G442. PubMed ID: 29792531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysophosphatidic acid modulates CD8 T cell immunosurveillance and metabolism to impair anti-tumor immunity.
    Turner JA; Fredrickson MA; D'Antonio M; Katsnelson E; MacBeth M; Van Gulick R; Chimed TS; McCarter M; D'Alessandro A; Robinson WA; Couts KL; Pelanda R; Klarquist J; Tobin RP; Torres RM
    Nat Commun; 2023 Jun; 14(1):3214. PubMed ID: 37270644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of Intestinal Epithelial Permeability by Lysophosphatidic Acid Receptor 5.
    Wang M; He P; Han Y; Dong L; Yun CC
    Cell Mol Gastroenterol Hepatol; 2021; 12(3):1073-1092. PubMed ID: 33975030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysophosphatidic Acid Is an Inflammatory Lipid Exploited by Cancers for Immune Evasion
    Mathew D; Torres RM
    Front Immunol; 2020; 11():531910. PubMed ID: 33584637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LPA
    Minami K; Ueda N; Ishimoto K; Tsujiuchi T
    Exp Cell Res; 2020 Mar; 388(1):111813. PubMed ID: 31904382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different effects of lysophosphatidic acid receptor-2 (LPA
    Ishimoto K; Minami A; Minami K; Ueda N; Tsujiuchi T
    J Recept Signal Transduct Res; 2021 Feb; 41(1):93-98. PubMed ID: 32672083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diverse effects of LPA4, LPA5 and LPA6 on the activation of tumor progression in pancreatic cancer cells.
    Ishii S; Hirane M; Fukushima K; Tomimatsu A; Fukushima N; Tsujiuchi T
    Biochem Biophys Res Commun; 2015 May; 461(1):59-64. PubMed ID: 25849892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Edg family LPA receptors: the cutting edge of LPA research.
    Yanagida K; Ishii S
    J Biochem; 2011 Sep; 150(3):223-32. PubMed ID: 21746769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of lysophosphatidic acid receptor-5 on cellular functions of sarcoma cells.
    Araki M; Kitayoshi M; Dong Y; Hirane M; Ozaki S; Mori S; Fukushima N; Honoki K; Tsujiuchi T
    Growth Factors; 2014 Jun; 32(3-4):117-22. PubMed ID: 24798396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysophosphatidic Acid Receptor 5 (LPA
    Joshi L; Plastira I; Bernhart E; Reicher H; Koshenov Z; Graier WF; Vujic N; Kratky D; Rivera R; Chun J; Sattler W
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysophosphatidic acid receptor 5 inhibits B cell antigen receptor signaling and antibody response.
    Hu J; Oda SK; Shotts K; Donovan EE; Strauch P; Pujanauski LM; Victorino F; Al-Shami A; Fujiwara Y; Tigyi G; Oravecz T; Pelanda R; Torres RM
    J Immunol; 2014 Jul; 193(1):85-95. PubMed ID: 24890721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LPA5 is abundantly expressed by human mast cells and important for lysophosphatidic acid induced MIP-1β release.
    Lundequist A; Boyce JA
    PLoS One; 2011 Mar; 6(3):e18192. PubMed ID: 21464938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autotaxin and LPA1 and LPA5 receptors exert disparate functions in tumor cells versus the host tissue microenvironment in melanoma invasion and metastasis.
    Lee SC; Fujiwara Y; Liu J; Yue J; Shimizu Y; Norman DD; Wang Y; Tsukahara R; Szabo E; Patil R; Banerjee S; Miller DD; Balazs L; Ghosh MC; Waters CM; Oravecz T; Tigyi GJ
    Mol Cancer Res; 2015 Jan; 13(1):174-85. PubMed ID: 25158955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysophosphatidic acid-induced itch is mediated by signalling of LPA
    Kittaka H; Uchida K; Fukuta N; Tominaga M
    J Physiol; 2017 Apr; 595(8):2681-2698. PubMed ID: 28176353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysophosphatidic acid receptor type 2 activation contributes to secondary damage after spinal cord injury in mice.
    López-Serrano C; Santos-Nogueira E; Francos-Quijorna I; Coll-Miró M; Chun J; López-Vales R
    Brain Behav Immun; 2019 Feb; 76():258-267. PubMed ID: 30550929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.